Two molecular control factors play a decisive role in what is known as splicing, the cutting and assembly of mature messenger ...
Avidity Biosciences, Inc.'s innovative AOC platform and promising clinical programs make it a high-risk, high-reward ...
Proper splicing requires efficient spliceosome assembly. Here the authors reveal that zinc finger protein 207 interacts with the U1 small nuclear ribonucleoprotein to accelerate spliceosome ...
The discovery could pave the way for a groundbreaking RNA-based multi-cancer treatment. Alternative RNA splicing functions ...
A team of researchers has identified a mechanism that regulates the production of two different proteins from the same gene.
3d
News-Medical.Net on MSNGroundbreaking study unveils key mechanism for neuronal identity regulationA team of researchers from the Institute for Neurosciences, a joint center of the Spanish National Research Council (CSIC) and the Miguel Hernández University (UMH) of Elche, in collaboration with ...
Splicing is an essential process in gene expression, through which non-coding fragments of messenger RNA are removed to generate functional proteins. In some cases, this process allows a single ...
A team of researchers from the Institute for Neurosciences, a joint center of the Spanish National Research Council (CSIC) and the Miguel Hernández ...
3d
AZoLifeSciences on MSNScientists Identify Crucial Mechanism for Maintaining Neuronal Identity in the BrainA team of researchers from the Institute for Neurosciences, a joint center of the Spanish National Research Council (CSIC) ...
1d
Clinical Trials Arena on MSNDuchenne muscular dystrophy: Five trials to watchAmid readouts from the Muscular Dystrophy Association’s annual meeting, the Clinical Trials Arena evaluates five DMD trials to keep an eye on in 2025.
Following the COVID-19 pandemic, mRNA-based vaccines have been shown to provide rapid and precise immune responses, however, this technology has much wider applications. Many leading pharma and ...
In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other stocks with potential to explode in 2025. The recent pullback in US equities can be a sign of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results